Human TNFRSF21/DR6 recombinant protein

Human TNFRSF21/DR6 recombinant protein

• DataSheet
• Material Safety Data Sheets (MSDS)

TNFRSF21 (death receptor-6, DR6) is an orphan TNF receptor superfamily member and belongs to a subgroup of receptors called death receptors. This type I transmembrane receptor possesses four extracellular cysteine-rich motifs and a cytoplasmic death domain. DR6 is an extensively posttranslationally modified transmembrane protein and that N- and O-glycosylations of amino acids in its extracellular part. DR6 interacts with the adaptor protein TRADD and mediates signal transduction through its death domain, and expression of DR6 in mammalian cells induces activation of both NF-kappaB and JNK and cell apoptosis. DR6 knockout mice have enhanced CD4+ T cell proliferation and Th2 cytokine production, suggested that DR6 serves as an important regulatory molecule in T-helper cell activation, and is involved in inflammation and immune regulation. DR6 is expressed ubiquitously with high expression in lymphoid organs, heart, brain and pancreas. Some tumor cells overexpress DR6, typically in conjunction with elevated anti-apoptosis molecules. DR6 may also be involved in tumor cell survival and immune evasion, which is subject to future investigations.

Tumor necrosis factor receptor superfamily, member 21, isoform CRA_b

TNFRSF21; AA959878; BM-018; DR6; TR7; MGC31965; R74815; CD358

O75509

TNFRSF21; hCG_2000710

Human Cells

The mature form of human DR6 (NP_055267.1) extracellular domain (Met 1-Leu 350) with five amino acids (DDDDK) at the C-terminus was expressed and purified.

Human

The recombinant human DR6 consists of 315 amino acids and predicts a molecular mass of 34.2 kDa. By SDS-PAGE under reducing conditions, the apparent molecular mass of rhDR6 is approximately 55-60 kDa due to the glycosylation.

> 95 % as determined by SDS-PAGE